Added to Saved items
This page has been archived. It has not been updated since 24/11/2014. External links and references may no longer work.
This article is for Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Read COVID-19 guidance from NICE

Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.

Synonyms: multiple endochondromatosis, dyschondroplasia, endochondromatosis

Enchondromas are common intraosseous benign cartilaginous tumours, that develop in close proximity to growth plate cartilage. When multiple enchondromas are present, the condition is called enchondromatosis, also known as Ollier's disease (World Health Organization (WHO) terminology).[1] When it is associated with haemangioma it is called Maffucci's syndrome. Disruption of musculoskeletal growth, development and function is the major cause for concern. There is also a risk of malignant change to osteosarcoma, chondrosarcoma or other bone tumours.

  • Ollier's disease (and Maffucci's syndrome) are usually non-familial disorders. Both disorders thus appear to occur spontaneously and are not inherited.
  • Although an identical heterozygous mutation in the PTHR1 gene has been identified, other mutations in this gene were not identified in additional patients with this disorder. These studies suggest that the cause of Ollier's disease is heterogeneous and raise the possibility that two (or more) genetic mutations are required to develop the disease. The development of enchondromas could thus be caused by a germ line mutation associated with a somatic mosaic mutation.
  • Additional mutational events may underlie progression from enchondromas to tumours.
  • Ollier's disease is very rare. The estimated prevalence of Ollier's disease is 1/100,000.[1]
  • Maffucci's syndrome is even rarer.
  • Solitary endochondromas are most commonly discovered between 20 and 40 years of age but Ollier's disease tends to present before the age of 10 years.
  • Boys are affected twice as often as girls.

There are six types of enchondromatosis but three are more common.

  • In Ollier's disease there are multiple enchondromas that are mostly unilateral or unevenly distributed throughout the metaphyses of the long bones, sparing the cranium and spine.
  • In Maffucci's syndrome the enchondromas occur with multiple cutaneous haemangiomas that appear as soft tissue calcifications or phleboliths on X-ray.
  • If there is symmetrical involvement throughout the body, including the cranium, hands and feet, it is known as generalised enchondromatosis.

The lesions of Ollier's disease tend to be bilateral but to predominate on one side. Enchondromas usually occur in the short tubular bones of the hands and feet as well as long bones of upper and lower extremities. Palpable masses develop that may cause angular deformity and asymmetrical growth. The masses increase in size as the child grows, along with asymmetrical shortening of a limb and either genu varus or genu valgus deformities. Varus deformity is very common.

The differential diagnosis may include:

  • Hereditary multiple endochondromatosis (HME). HME is an autosomal dominant disorder characterised by multiple bone tumours capped by cartilage, that occur mostly in the metaphyses of long bones.
  • Other rare forms of chondromatosis (which include metachondromatosis, spondyloenchondroplasia and genochondromatosis types I and II).
  • Polyostotic fibrous dysplasia.
  • Diaphyseal aclasis.
  • Kaposi's sarcoma.
  • Klippel-Trénaunay syndrome.
  • The basic investigation is X-ray. Most cases have diaphyseal or metaphyseal lesions which do not cross the growth plate until after it has closed. Sometimes enchondromatosis will affect the metaphyseal and epiphyseal regions. When enchondromas cross the growth plate they cause severe limb length deformities and angular deformities.
  • CT or MRI scanning may be required, as may bone scans. They are indicated for the evaluation and surveillance of lesions that become symptomatic (pain, and increase in size).[1]
  • Biopsy of suspicious lesions may be required.

The most common difficulties experienced with Ollier's disease concern mobility and hand function. These difficulties are managed with physiotherapy and orthotics.

Serial surgery may be required for the distortion of joints and when limbs are of unequal lengths.[2, 3, 4, 5]

As well as the problem of asymmetrical growth there can be pathological fracture and malignant change. The rate of chondrosarcoma in Ollier's disease has been estimated at 30-50%.[6]

  • The prognosis for Ollier's disease is difficult to assess as there is a paucity of peer-reviewed research and much of it is contradictory.
  • As is generally the case, forms with an early onset appear more severe.
  • The reported incidence of malignant transformation is variable and estimated to occur in 5-50%.

Despite acceptance that Ollier's disease carries a risk of malignant change there is little in the literature to quantify the risk and no agreed protocol for screening.

Louis Xavier Édouard Léopold Ollier was a French surgeon who was born in 1830 and died in 1900. He was an intern of Lyon Hospital in 1851, graduated in medicine with distinction in 1856 and, in 1857, obtained his doctorate at Paris with a dissertation based on histological studies of 400 malignant neoplasms. His most notable work was in bone and joint surgery. In 1877 a new medical faculty was established in Lyon and he was appointed professor of clinical surgery.

Angelo Maffucci was an Italian pathologist who was born in 1847 and died in 1903. He graduated in Naples in 1872. In 1882 he became head of general pathology at Messina University and the following year he received the chair of anatomical pathology at Catania. In 1884 he was appointed to the chair of pathological anatomy in Pisa, where he died in 1903. He made considerable contributions that were poorly recognised outside Italy.

Further reading and references

  1. Silve C, Juppner H; Ollier disease. Orphanet J Rare Dis. 2006 Sep 221:37.

  2. Baumgart R, Burklein D, Hinterwimmer S, et al; The management of leg-length discrepancy in Ollier's disease with a fully implantable lengthening nail. J Bone Joint Surg Br. 2005 Jul87(7):1000-4.

  3. Kolodziej L, Kolban M, Zacha S, et al; The use of the Ilizarov technique in the treatment of upper limb deformity in patients with Ollier's disease. J Pediatr Orthop. 2005 Mar-Apr25(2):202-5.

  4. Watanabe K, Tsuchiya H, Sakurakichi K, et al; Treatment of lower limb deformities and limb-length discrepancies with the external fixator in Ollier's disease. J Orthop Sci. 2007 Sep12(5):471-5. Epub 2007 Sep 28.

  5. Martson A, Haviko T, Kirjanen K; Extensive limb lengthening in Ollier's disease: 25-year follow-up. Medicina (Kaunas). 200541(10):861-6.

  6. Horvai A, Unni KK; Premalignant conditions of bone. J Orthop Sci. 2006 Jul11(4):412-23.